Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:CL 16:0_18:1_18:1_20:4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004300 AN007153 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007153 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004300 AN007155 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007155 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST003341 AN005476 Untargeted Lipidomic Profiling of Canine Cancer Cell Lines Cultured cells Dog Cancer Kojin Therapeutics, Inc. LC-MS
ST002145 AN003511 The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy Cultured cells Mouse Diabetes University of Texas MD Anderson Cancer Center LC-MS
ST002145 AN003512 The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy Cultured cells Mouse Diabetes University of Texas MD Anderson Cancer Center LC-MS
  logo